COR logo

Cencora, Inc. (COR)

Profile

Full Name

Cencora, Inc.

Ticker

NYSE: COR

Exchange

NYSE

Sector

Healthcare

Industry

Medical Distribution

Country

United States

IPO

April 4, 1995

Indexes

S&P 500

Website

http://www.cencora.com

Employees

42000

Key Details

Price

$295.21(-0.71%)

Market cap

Last Dividend

$0.55

TTM Dividend yield

0.73%

Annual revenue

$293.96B(+12.12% YoY)

Annual EPS

$7.53(-11.72% YoY)

PE ratio

34.25

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $295.21
    COR price is $295.21

    30-Day Relative Volume

    0.70
    COR 30-day relative volume is 0.70

    Price Performance

    Price Most recent change

    -0.71%
    COR price was down -0.71% on Jul 11, 2025

    Price YTD change

    +31.39%
    COR price is up +31.39% since January 1st

    Price 1-year change

    +32.98%
    COR price is up +32.98% year-on-year

    Price 3-year change

    +108.89%
    COR price is up +108.89% over the past 3 years

    Price Range

    Price All-time high

    $309.35
    COR price is currently -4.57% below its historical high of $309.35

    Price 3-year low

    $135.14
    COR price is currently +118.45% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $57.22B
    COR market capitalization is $57.22 billion

    Market cap 3-year change

    +94.79%
    COR market capitalization is up +94.79% over the past 3 years

    Market cap All-time high

    $59.03B
    COR market capitalization is currently -3.08% below its historical high of $59.03 billion

    Market cap sector rank

    97.6%
    COR market capitalization is higher than 97.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.62%
    COR shares outstanding is down -1.62% year-on-year

    Shares Outstanding 3-Year Change

    -6.75%
    COR shares outstanding is down -6.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.03
    COR beta is 0.03

    200-day SMA

    $258.56
    COR price is currently +14.17% above its 200-day simple moving average

    50-day SMA

    $291.78
    COR price is currently +1.18% above its 50-day simple moving average

    RSI

    50.98
    COR 14-day relative strength index is 50.98

    Volume

    0.70
    COR 30-day relative volume is 0.70

    ATR

    $5.44
    COR average true range is $5.44

    10-day Historical Volatility

    21.70%
    COR 10-day historical volatility is 21.70%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.55
    COR last dividend was $0.55 per share, with an ex-dividend date of May 16, 2025

    Next Dividend

    -
    COR next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $2.04
    COR annual dividend per share is $2.04

    Dividend per share Sector Rank

    70.59%
    COR annual dividend per share is higher than 70.59% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5.15%
    COR annual dividend per share is up +5.15% year-on-year

    Dividend per share 3-Year Change

    +15.91%
    COR annual dividend per share is up +15.91% over the past 3 years

    Dividend yield

    Dividend yield

    0.69%
    COR annual dividend yield is 0.69%

    Dividend yield Sector Rank

    21.43%
    COR annual dividend yield is higher than 21.43% of companies in Healthcare sector

    Other

    Payout ratio

    27.58%
    COR annual payout ratio is 27.58%

    Dividends paid

    $416.17M
    COR annual dividends paid is $416.17 million

    Free cash flow

    $3.00B
    COR annual free cash flow is $3.00 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $293.96B
    COR annual revenue is $293.96 billion

    Revenue Analysts estimate

    $321.59B
    COR annual revenue is currently -8.59% lower than the consensus analysts' forecast

    Revenue 1-year change

    +12.12%
    COR annual revenue is up +12.12% year-on-year

    Revenue Sector rank

    99.66%
    COR annual revenue is higher than 99.66% of companies in Healthcare sector

    EPS

    EPS

    $7.53
    COR annual earnings per share is $7.53

    EPS Analysts estimate

    $15.80
    COR annual earnings per share is currently -52.35% lower than the consensus analysts' forecast

    EPS 1-year change

    -11.72%
    COR annual earnings per share is down -11.72% year-on-year

    EPS Sector rank

    97.09%
    COR annual earnings per share is higher than 97.09% of companies in Healthcare sector

    Profit

    Gross profit

    $9.91B
    COR annual gross profit is $9.91 billion

    Gross margin

    3.37%
    COR annual gross profit margin is 3.37%

    Operating profit

    $3.16B
    COR annual operating income is $3.16 billion

    Operating margin

    1.07%
    COR annual operating profit margin is 1.07%

    Net income

    $1.51B
    COR annual net profit is $1.51 billion

    Net margin

    0.51%
    COR annual net profit margin is 0.51%

    Expenses

    Total expenses

    $290.80B
    COR annual total expenses is $290.80 billion

    Operating expenses

    $6.75B
    COR annual total operating expenses is $6.75 billion

    Cost of goods sold

    $284.05B
    COR annual cost of goods sold is $284.05 billion

    Selling, general & administrative expenses

    $5.66B
    COR annual SGA is $5.66 billion

    Depreciation and amortization

    $1.12B
    COR annual depreciation & amortization is $1.12 billion

    Interest expense

    $248.68M
    COR annual interest expense is $248.68 million

    Income tax

    $484.70M
    COR annual income tax is $484.70 million

    EBIT & EBITDA

    EBIT

    $2.25B
    COR annual earnings before interest & taxes is $2.25 billion

    EBITDA

    $3.37B
    COR annual EBITDA is $3.37 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $67.10B
    COR annual total assets is $67.10 billion

    Non current assets

    $19.38B
    COR annual long term assets is $19.38 billion

    Current assets

    $47.72B
    COR annual total current assets is $47.72 billion

    Cash and cash equivalents

    $3.13B
    COR annual cash & cash equivalents is $3.13 billion

    Accounts receivable

    $23.87B
    COR annual accounts receivable is $23.87 billion

    Inventory

    $19.00B
    COR annual inventory is $19.00 billion

    Liabilities

    Total liabilities

    $66.31B
    COR annual total liabilities is $66.31 billion

    Long term liabilities

    $12.04B
    COR annual total long term liabilities is $12.04 billion

    Current liabilities

    $54.28B
    COR annual total current liabilities is $54.28 billion

    Accounts payable

    $50.94B
    COR annual accounts payable is $50.94 billion

    Debt

    Total debt

    $4.39B
    COR annual total debt is $4.39 billion

    Total debt 1-year change

    -8.34%
    COR annual total debt is down -8.34% year-on-year

    Long term debt

    $3.81B
    COR annual long term debt is $3.81 billion

    Short term debt

    $576.33M
    COR annual short term debt is $576.33 million

    Equity & Capital

    Shareholders equity

    $645.94M
    COR annual stockholders equity is $645.94 million

    Book value

    $645.94M
    COR annual book value is $645.94 million

    Retained earnings

    $5.42B
    COR annual retained earnings is $5.42 billion

    Working capital

    -$6.56B
    COR annual working capital is -$6.56 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $3.48B
    COR annual cash flow from operations is $3.48 billion

    Cash from operations 1-year change

    -10.91%
    COR annual cash flow from operations is down -10.91% year-on-year

    Cash from investing

    -$618.10M
    COR annual cash flow from investing activities is -$618.10 million

    Cash from investing 1-year change

    +76.25%
    COR annual cash flow from investing activities is up +76.25% year-on-year

    Cash from financing

    -$2.33B
    COR annual cash flow from financing activities is -$2.33 billion

    Cash from financing 1-year change

    -4.89%
    COR annual cash flow from financing activities is down -4.89% year-on-year

    CAPEX

    CAPEX

    $487.17M
    COR annual capital expenditures is $487.17 million

    CAPEX 1-year change

    +6.29%
    COR annual capital expenditures is up +6.29% year-on-year

    Free Cash Flow

    Free cash flow

    $3.00B
    COR annual free cash flow is $3.00 billion

    Free cash flow 1-year change

    -13.19%
    COR annual free cash flow is down -13.19% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    3.37%
    COR annual gross profit margin is 3.37%

    Operating margin

    1.07%
    COR annual operating profit margin is 1.07%

    Net margin

    0.51%
    COR annual net profit margin is 0.51%

    ROA & ROE

    ROA

    2.33%
    COR annual return on assets is 2.33%

    ROE

    207.72%
    COR annual return on equity is 207.72%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    34.25
    COR price to earnings ratio is 34.25

    PE ratio Sector rank

    63.85%
    COR price to earnings ratio is higher than 63.85% of companies in Healthcare sector

    PB Ratio

    PB ratio

    56.49
    COR price to book ratio is 56.49

    PB ratio Sector rank

    98.51%
    COR price to book ratio is higher than 98.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.18
    COR price to sales ratio is 0.18

    PS ratio Sector rank

    5.76%
    COR price to sales ratio is higher than 5.76% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $63.10B
    COR enterprise value is $63.10 billion

    Enterprise value Sector rank

    97.5%
    COR enterprise value is higher than 97.5% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    16.98
    COR EV/EBITDA is 16.98

    EV/EBITDA Sector rank

    90.06%
    COR EV/EBITDA is higher than 90.06% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.88
    COR annual current ratio is 0.88

    Quick ratio

    0.53
    COR annual quick ratio is 0.53

    Leverage

    Debt to equity

    6.79
    COR annual debt to equity ratio is 6.79

    Interest coverage ratio

    9.06
    COR annual interest coverage ratio is 9.06

    Risk & Stability

    Piotroski F-Score

    7
    COR piotroski f-score is 7

    Altman Z-Score

    5.00
    COR altman z-score is 5.00

    Analyst ratings

    Recent major analysts updates

    Jun 30, 25 Jefferies
    Hold
    Jun 3, 25 Wells Fargo
    Overweight
    May 8, 25 Citigroup
    Buy
    May 8, 25 Baird
    Outperform
    Apr 29, 25 UBS
    Buy
    Apr 11, 25 B of A Securities
    Neutral
    Mar 14, 25 Wells Fargo
    Equal-Weight
    Feb 6, 25 Evercore ISI Group
    Outperform
    Jan 29, 25 Wells Fargo
    Equal-Weight
    Jan 24, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with COR included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Best performing stocks last 5 years
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Cencora, Inc.?
    • Does Cencora, Inc. pay dividends?
    • What sector is Cencora, Inc. in?
    • What industry is Cencora, Inc. in?
    • What country is Cencora, Inc. based in?
    • When did Cencora, Inc. go public?
    • Is Cencora, Inc. in the S&P 500?
    • Is Cencora, Inc. in the NASDAQ 100?
    • Is Cencora, Inc. in the Dow Jones?
    • When was Cencora, Inc.'s last earnings report?
    • When does Cencora, Inc. report earnings?

    What is the ticker symbol for Cencora, Inc.?

    The ticker symbol for Cencora, Inc. is NYSE:COR

    Does Cencora, Inc. pay dividends?

    Yes, Cencora, Inc. pays dividends. The last payment was $0.55, with an ex-dividend date on May 16, 2025

    What sector is Cencora, Inc. in?

    Cencora, Inc. is in the Healthcare sector

    What industry is Cencora, Inc. in?

    Cencora, Inc. is in the Medical Distribution industry

    What country is Cencora, Inc. based in?

    Cencora, Inc. is headquartered in United States

    When did Cencora, Inc. go public?

    Cencora, Inc.'s initial public offering (IPO) was on April 4, 1995

    Is Cencora, Inc. in the S&P 500?

    Yes, Cencora, Inc. is included in the S&P 500 index

    Is Cencora, Inc. in the NASDAQ 100?

    No, Cencora, Inc. is not included in the NASDAQ 100 index

    Is Cencora, Inc. in the Dow Jones?

    No, Cencora, Inc. is not included in the Dow Jones index

    When was Cencora, Inc.'s last earnings report?

    Cencora, Inc.'s most recent earnings report was on May 7, 2025

    When does Cencora, Inc. report earnings?

    The next expected earnings date for Cencora, Inc. is August 6, 2025
    On this page